3-(2-oxo-1,3-oxazolidin-3-yl)-N-(1-piperidin-1-ylpropan-2-yl)benzamide

C18H25N3O3 — CID 60508452

IUPAC3-(2-oxo-1,3-oxazolidin-3-yl)-N-(1-piperidin-1-ylpropan-2-yl)benzamide
SMILESCC(CN1CCCCC1)NC(=O)c1cccc(N2CCOC2=O)c1
InChIInChI=1S/C18H25N3O3/c1-14(13-20-8-3-2-4-9-20)19-17(22)15-6-5-7-16(12-15)21-10-11-24-18(21)23/h5-7,12,14H,2-4,8-11,13H2,1H3,(H,19,22)
InChIKeyWZYIVKBXDGESSA-UHFFFAOYSA-N
MW331.42 g/mol
LogP2.25
Rot. Bonds5

About 3-(2-oxo-1,3-oxazolidin-3-yl)-N-(1-piperidin-1-ylpropan-2-yl)benzamide

3-(2-oxo-1,3-oxazolidin-3-yl)-N-(1-piperidin-1-ylpropan-2-yl)benzamide (PubChem CID 60508452) has the molecular formula C18H25N3O3 and a molecular weight of 331.42 g/mol. Its IUPAC name is 3-(2-oxo-1,3-oxazolidin-3-yl)-N-(1-piperidin-1-ylpropan-2-yl)benzamide.

Molecular Properties

Compound Name3-(2-oxo-1,3-oxazolidin-3-yl)-N-(1-piperidin-1-ylpropan-2-yl)benzamide
PubChem CID60508452
Molecular FormulaC18H25N3O3
Molecular Weight331.42 g/mol
Exact Mass331.19
IUPAC Name3-(2-oxo-1,3-oxazolidin-3-yl)-N-(1-piperidin-1-ylpropan-2-yl)benzamide
SMILESCC(CN1CCCCC1)NC(=O)c1cccc(N2CCOC2=O)c1
InChIInChI=1S/C18H25N3O3/c1-14(13-20-8-3-2-4-9-20)19-17(22)15-6-5-7-16(12-15)21-10-11-24-18(21)23/h5-7,12,14H,2-4,8-11,13H2,1H3,(H,19,22)
InChIKeyWZYIVKBXDGESSA-UHFFFAOYSA-N
XLogP2.25
TPSA61.88 Ų
H-Bond Donors1
H-Bond Acceptors4
Rotatable Bonds5
Heavy Atoms24
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500331.42
LogP ≤ 52.25
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 104

Analyze 3-(2-oxo-1,3-oxazolidin-3-yl)-N-(1-piperidin-1-ylpropan-2-yl)benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

3-iodo-N-(1-piperidin-1-ylpropan-2-yl)benzamide
CID 54937836
3-amino-N-(1-piperidin-1-ylpropan-2-yl)benzamide;dihydrochloride
CID 119851488
N-(1-piperidin-1-ylpropan-2-yl)-3-sulfanylbenzamide
CID 107025389
3-(2-oxo-1,3-oxazolidin-3-yl)-N-[(1R)-1-pyridin-4-ylethyl]benzamide
CID 94029882
3-cyano-N-[(2R)-1-(2-oxo-1,3-oxazolidin-3-yl)propan-2-yl]benzamide
CID 94814841
N-[[(2S)-1-oxaspiro[4.5]decan-2-yl]methyl]-3-(2-oxo-1,3-oxazolidin-3-yl)benzamide
CID 99795460
N-[1-(2-fluorophenoxy)-3,3-dimethylbutan-2-yl]-3-(2-oxo-1,3-oxazolidin-3-yl)benzamide
CID 86940735
N-[(2R)-1-pyrrolidin-1-ylpropan-2-yl]-3-[2-(trifluoromethyl)phenyl]benzamide
CID 125172341
4-fluoro-3-methyl-N-(1-piperidin-1-ylpropan-2-yl)benzamide
CID 63213435
3-carbamothioyl-N-(1-morpholin-4-ylpropan-2-yl)benzamide
CID 61499952
4-amino-3-methoxy-N-(1-piperidin-1-ylpropan-2-yl)benzamide
CID 104782742
N-[(1-benzylpiperidin-4-yl)methyl]-3-(2-oxo-1,3-oxazolidin-3-yl)benzamide
CID 99841245

Frequently Asked Questions

What is the IUPAC name of 3-(2-oxo-1,3-oxazolidin-3-yl)-N-(1-piperidin-1-ylpropan-2-yl)benzamide?
The IUPAC name of 3-(2-oxo-1,3-oxazolidin-3-yl)-N-(1-piperidin-1-ylpropan-2-yl)benzamide (CID 60508452) is 3-(2-oxo-1,3-oxazolidin-3-yl)-N-(1-piperidin-1-ylpropan-2-yl)benzamide.
What is the SMILES notation for 3-(2-oxo-1,3-oxazolidin-3-yl)-N-(1-piperidin-1-ylpropan-2-yl)benzamide?
The canonical SMILES for 3-(2-oxo-1,3-oxazolidin-3-yl)-N-(1-piperidin-1-ylpropan-2-yl)benzamide is CC(CN1CCCCC1)NC(=O)c1cccc(N2CCOC2=O)c1.
What is the InChIKey of 3-(2-oxo-1,3-oxazolidin-3-yl)-N-(1-piperidin-1-ylpropan-2-yl)benzamide?
The InChIKey is WZYIVKBXDGESSA-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H25N3O3/c1-14(13-20-8-3-2-4-9-20)19-17(22)15-6-5-7-16(12-15)21-10-11-24-18(21)23/h5-7,12,14H,2-4,8-11,13H2,1H3,(H,19,22).
What are the key properties of 3-(2-oxo-1,3-oxazolidin-3-yl)-N-(1-piperidin-1-ylpropan-2-yl)benzamide?
3-(2-oxo-1,3-oxazolidin-3-yl)-N-(1-piperidin-1-ylpropan-2-yl)benzamide has a molecular weight of 331.42 g/mol, XLogP of 2.25, 5 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 3-(2-oxo-1,3-oxazolidin-3-yl)-N-(1-piperidin-1-ylpropan-2-yl)benzamide is sourced from PubChem (CID 60508452), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).